Tag: Diabetes: Type II
Chronic Hepatitis B Prevalence Higher in Those With T2DM
Findings based on comparison to adult-onset autoimmune diabetes, controls
Lowest Glucose Variability for Insulin + GLP-1 RA in T2DM
Lowest glucose variability, hypoglycemia for basal insulin + GLP-1 receptor agonist regimen
Long-Term DPP4-Inhibitor Use Not Tied to Fracture Risk in T2DM
No increase in risk of any fracture, osteoporotic or hip fractures with continuous long-term use
Data-Driven Algorithm Yields Notable Improvements in HbA1c
Posttreatment HbA1c lower under algorithm-recommended tx versus standard of care
Urine Haptoglobin Can Predict Kidney Damage in T2DM
Patients with haptoglobulinuria had elevated incidence of chronic renal insufficiency
Functionally ID’d Variants in HNF1A Linked to Diabetes Risk
Functionally characterized variants that reduce HNF-1A transcriptional activity strongly linked to diabetes
Interrupting Sitting Time Ups Blood Glucose Control in T2DM
Breaking sitting with standing, light-intensity walking may be alternative to structured exercise
Metabolic Benefit Same With Similar Weight Loss After Surgery
Findings among obese patients with diabetes undergoing either gastric bypass, banding
Follow-Up Phone Calls May Boost Glycemic Control in T2DM
No statistically significant change in hemoglobin A1c, but clinically significant change observed
Metformin Alters Gut Microbiota Composition in Diabetes
Higher relative abundance of A. muciniphila, SCFA-producing microbiota for metformin-treated diabetes
